Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Desensitization, Immunologic | 12 | 2019 | 563 | 2.240 |
Why?
|
Drug Hypersensitivity | 20 | 2019 | 922 | 2.060 |
Why?
|
Asthma | 18 | 2021 | 6274 | 1.350 |
Why?
|
Antibodies, Anti-Idiotypic | 8 | 2014 | 355 | 1.300 |
Why?
|
Allergens | 9 | 2019 | 1445 | 0.890 |
Why?
|
Rhinitis, Allergic, Perennial | 3 | 2010 | 60 | 0.810 |
Why?
|
Rhinitis, Allergic, Seasonal | 3 | 2010 | 105 | 0.790 |
Why?
|
Skin Tests | 9 | 2017 | 639 | 0.770 |
Why?
|
Carboplatin | 5 | 2016 | 798 | 0.750 |
Why?
|
Immunoglobulin E | 9 | 2017 | 1510 | 0.750 |
Why?
|
Penicillin G Benzathine | 1 | 2017 | 25 | 0.580 |
Why?
|
Soft Tissue Infections | 1 | 2019 | 168 | 0.550 |
Why?
|
In Situ Hybridization | 10 | 1998 | 1906 | 0.520 |
Why?
|
Rheumatic Heart Disease | 1 | 2017 | 164 | 0.520 |
Why?
|
Organoplatinum Compounds | 2 | 2015 | 408 | 0.500 |
Why?
|
Pharyngitis | 1 | 2017 | 222 | 0.500 |
Why?
|
Allergy and Immunology | 5 | 2019 | 175 | 0.490 |
Why?
|
Polymerase Chain Reaction | 11 | 1998 | 6091 | 0.450 |
Why?
|
Scopolamine Derivatives | 1 | 2013 | 24 | 0.440 |
Why?
|
Vancomycin | 2 | 2016 | 506 | 0.420 |
Why?
|
Streptococcal Infections | 1 | 2017 | 619 | 0.410 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 110 | 0.410 |
Why?
|
Cholinergic Antagonists | 1 | 2013 | 167 | 0.410 |
Why?
|
Anti-Allergic Agents | 3 | 2010 | 157 | 0.380 |
Why?
|
Influenza Vaccines | 1 | 2019 | 781 | 0.370 |
Why?
|
Secondary Prevention | 1 | 2017 | 1479 | 0.360 |
Why?
|
Hypersensitivity | 4 | 2022 | 1172 | 0.360 |
Why?
|
Paclitaxel | 2 | 2017 | 1737 | 0.360 |
Why?
|
Pets | 1 | 2010 | 47 | 0.350 |
Why?
|
Mast Cells | 1 | 2017 | 1407 | 0.350 |
Why?
|
Anti-Asthmatic Agents | 5 | 2016 | 578 | 0.350 |
Why?
|
Skin Diseases | 1 | 2019 | 1099 | 0.340 |
Why?
|
Eosinophilia | 2 | 2012 | 558 | 0.320 |
Why?
|
Lymphoma | 1 | 2017 | 1907 | 0.300 |
Why?
|
Biological Factors | 1 | 2009 | 158 | 0.300 |
Why?
|
Adrenal Cortex Hormones | 3 | 2013 | 1891 | 0.300 |
Why?
|
Exanthema | 1 | 2012 | 504 | 0.280 |
Why?
|
Th2 Cells | 2 | 2010 | 1079 | 0.280 |
Why?
|
Antibodies, Monoclonal | 5 | 2010 | 9263 | 0.280 |
Why?
|
Respiratory Mucosa | 1 | 2010 | 439 | 0.270 |
Why?
|
Immunologic Factors | 2 | 2019 | 1600 | 0.250 |
Why?
|
Anti-Bacterial Agents | 6 | 2017 | 7471 | 0.250 |
Why?
|
Immunization | 1 | 2010 | 1220 | 0.250 |
Why?
|
Eosinophils | 1 | 2010 | 955 | 0.250 |
Why?
|
Immunomodulation | 1 | 2009 | 550 | 0.240 |
Why?
|
Program Development | 1 | 2011 | 1296 | 0.240 |
Why?
|
Skin Neoplasms | 2 | 2014 | 5891 | 0.240 |
Why?
|
Immunologic Tests | 2 | 2015 | 104 | 0.230 |
Why?
|
Immunotherapy | 2 | 2010 | 4728 | 0.220 |
Why?
|
Rhinitis, Vasomotor | 1 | 2003 | 1 | 0.220 |
Why?
|
Infusions, Intravenous | 3 | 2019 | 2228 | 0.210 |
Why?
|
Anaphylaxis | 3 | 2020 | 758 | 0.190 |
Why?
|
Dendritic Cells | 2 | 2010 | 2757 | 0.190 |
Why?
|
Electronics, Medical | 1 | 2019 | 72 | 0.160 |
Why?
|
Histamine H1 Antagonists | 1 | 2019 | 101 | 0.160 |
Why?
|
Peanut Hypersensitivity | 1 | 2002 | 219 | 0.160 |
Why?
|
Humans | 70 | 2022 | 768451 | 0.160 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7451 | 0.160 |
Why?
|
Common Variable Immunodeficiency | 1 | 2019 | 100 | 0.160 |
Why?
|
Electronic Health Records | 1 | 2016 | 4877 | 0.150 |
Why?
|
Phospholipids | 2 | 1992 | 783 | 0.150 |
Why?
|
Vaccines, Synthetic | 1 | 2020 | 622 | 0.150 |
Why?
|
DNA, Viral | 3 | 1994 | 2206 | 0.150 |
Why?
|
Serum Sickness | 1 | 2017 | 27 | 0.150 |
Why?
|
Attitude to Health | 1 | 2007 | 2030 | 0.150 |
Why?
|
Toll-Like Receptor 9 | 2 | 2009 | 199 | 0.150 |
Why?
|
Tumor Lysis Syndrome | 1 | 2017 | 38 | 0.150 |
Why?
|
Penicillins | 2 | 2019 | 405 | 0.150 |
Why?
|
Immunity, Innate | 1 | 2010 | 3080 | 0.150 |
Why?
|
Injections, Intramuscular | 2 | 2017 | 557 | 0.150 |
Why?
|
Cats | 3 | 2010 | 978 | 0.140 |
Why?
|
Autoantibodies | 4 | 2019 | 2131 | 0.140 |
Why?
|
Bronchi | 2 | 2012 | 847 | 0.140 |
Why?
|
Risk | 4 | 2019 | 9642 | 0.140 |
Why?
|
Cell Degranulation | 1 | 2017 | 277 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 6 | 1993 | 2173 | 0.140 |
Why?
|
Myasthenia Gravis | 1 | 2019 | 218 | 0.140 |
Why?
|
Tryptases | 1 | 2017 | 176 | 0.130 |
Why?
|
Zambia | 1 | 2017 | 273 | 0.130 |
Why?
|
Pharmaceutical Preparations | 2 | 2015 | 1089 | 0.130 |
Why?
|
Platinum Compounds | 1 | 2016 | 95 | 0.130 |
Why?
|
Cystadenoma, Serous | 1 | 2016 | 100 | 0.130 |
Why?
|
Middle Aged | 27 | 2021 | 223418 | 0.130 |
Why?
|
Adult | 25 | 2021 | 223542 | 0.120 |
Why?
|
Referral and Consultation | 3 | 2019 | 3629 | 0.120 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13708 | 0.110 |
Why?
|
Oncology Service, Hospital | 1 | 2014 | 57 | 0.110 |
Why?
|
Hospitals, Special | 1 | 2014 | 90 | 0.110 |
Why?
|
Bronchial Hyperreactivity | 2 | 2010 | 301 | 0.110 |
Why?
|
Diphenhydramine | 2 | 2019 | 63 | 0.110 |
Why?
|
Data Mining | 1 | 2019 | 561 | 0.110 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2013 | 32 | 0.110 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2017 | 624 | 0.110 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2013 | 144 | 0.110 |
Why?
|
Infusion Pumps | 1 | 2014 | 163 | 0.110 |
Why?
|
Cytokines | 3 | 2017 | 7449 | 0.110 |
Why?
|
Female | 32 | 2021 | 396943 | 0.110 |
Why?
|
Physicians, Women | 1 | 2019 | 519 | 0.110 |
Why?
|
Male | 28 | 2021 | 364781 | 0.100 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 1993 | 111 | 0.100 |
Why?
|
Schools, Medical | 1 | 2019 | 881 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2013 | 4861 | 0.100 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 1994 | 333 | 0.100 |
Why?
|
Infusions, Parenteral | 1 | 2012 | 398 | 0.100 |
Why?
|
Morbidity | 1 | 2017 | 1760 | 0.100 |
Why?
|
Chromosomes, Human | 1 | 1994 | 444 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 1670 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 792 | 0.100 |
Why?
|
Disease Management | 2 | 2012 | 2533 | 0.090 |
Why?
|
Aged | 17 | 2021 | 171520 | 0.090 |
Why?
|
Herpesvirus 6, Human | 1 | 2012 | 98 | 0.090 |
Why?
|
Antilymphocyte Serum | 2 | 1990 | 491 | 0.090 |
Why?
|
Nephritis | 1 | 2012 | 147 | 0.090 |
Why?
|
Proviruses | 1 | 1992 | 320 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2019 | 1218 | 0.090 |
Why?
|
Pruritus | 1 | 2014 | 380 | 0.090 |
Why?
|
Antiphospholipid Syndrome | 1 | 1992 | 167 | 0.090 |
Why?
|
Translocation, Genetic | 2 | 1994 | 1395 | 0.090 |
Why?
|
Hypersensitivity, Immediate | 1 | 2013 | 350 | 0.090 |
Why?
|
Bronchial Provocation Tests | 1 | 2010 | 216 | 0.090 |
Why?
|
Preferred Provider Organizations | 1 | 2010 | 37 | 0.090 |
Why?
|
Lymphatic Diseases | 1 | 2012 | 320 | 0.090 |
Why?
|
Back Pain | 1 | 2014 | 547 | 0.090 |
Why?
|
Hepatitis | 1 | 2012 | 228 | 0.090 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2016 | 463 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2022 | 2260 | 0.080 |
Why?
|
Breath Tests | 2 | 2010 | 300 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2015 | 925 | 0.080 |
Why?
|
United States | 9 | 2020 | 73121 | 0.080 |
Why?
|
Tachycardia | 1 | 2012 | 599 | 0.080 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1487 | 0.080 |
Why?
|
Hospitals, General | 1 | 2013 | 807 | 0.080 |
Why?
|
Patient Compliance | 2 | 2011 | 2696 | 0.080 |
Why?
|
False Negative Reactions | 3 | 2015 | 575 | 0.080 |
Why?
|
Proton Pump Inhibitors | 1 | 2013 | 552 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 1727 | 0.080 |
Why?
|
Boston | 3 | 2021 | 9361 | 0.070 |
Why?
|
Sputum | 1 | 2010 | 511 | 0.070 |
Why?
|
Histamine H1 Antagonists, Non-Sedating | 1 | 2007 | 17 | 0.070 |
Why?
|
Nasal Obstruction | 1 | 2010 | 161 | 0.070 |
Why?
|
Virus Diseases | 1 | 1994 | 723 | 0.070 |
Why?
|
Health Maintenance Organizations | 1 | 2010 | 658 | 0.070 |
Why?
|
Abortion, Spontaneous | 1 | 1992 | 539 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15460 | 0.070 |
Why?
|
United States Food and Drug Administration | 2 | 2020 | 1669 | 0.070 |
Why?
|
Academic Medical Centers | 2 | 2014 | 2785 | 0.070 |
Why?
|
Ambulatory Care | 2 | 2017 | 2780 | 0.070 |
Why?
|
Time Factors | 5 | 2016 | 40271 | 0.070 |
Why?
|
Bronchoscopy | 1 | 2012 | 913 | 0.070 |
Why?
|
Drug Resistance | 1 | 2012 | 1599 | 0.070 |
Why?
|
Cell Count | 1 | 2010 | 1835 | 0.070 |
Why?
|
Agammaglobulinemia | 1 | 1987 | 174 | 0.060 |
Why?
|
Central Nervous System Diseases | 1 | 1990 | 521 | 0.060 |
Why?
|
Insurance Claim Review | 1 | 2010 | 745 | 0.060 |
Why?
|
Syndrome | 1 | 2012 | 3278 | 0.060 |
Why?
|
Dogs | 1 | 2010 | 3847 | 0.060 |
Why?
|
Evidence-Based Medicine | 2 | 2011 | 3708 | 0.060 |
Why?
|
Insect Bites and Stings | 1 | 2005 | 71 | 0.060 |
Why?
|
Thromboembolism | 1 | 1991 | 1006 | 0.060 |
Why?
|
Recurrence | 1 | 2017 | 8510 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2010 | 14728 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2021 | 59680 | 0.060 |
Why?
|
Fever | 1 | 2012 | 1622 | 0.060 |
Why?
|
Young Adult | 6 | 2017 | 60045 | 0.060 |
Why?
|
Behavior | 1 | 2007 | 545 | 0.060 |
Why?
|
RNA | 1 | 1994 | 2727 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1514 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2016 | 81834 | 0.060 |
Why?
|
Drug Design | 1 | 2009 | 1050 | 0.060 |
Why?
|
Anesthesia | 1 | 2014 | 1596 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2014 | 15965 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6537 | 0.050 |
Why?
|
Patient Education as Topic | 2 | 2011 | 2339 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6320 | 0.050 |
Why?
|
Epitopes | 2 | 2002 | 2526 | 0.050 |
Why?
|
Genes, Immunoglobulin | 3 | 1992 | 286 | 0.050 |
Why?
|
DNA | 2 | 1994 | 7213 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 13026 | 0.050 |
Why?
|
Adolescent | 6 | 2017 | 89168 | 0.050 |
Why?
|
Program Evaluation | 1 | 2011 | 2508 | 0.050 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 1992 | 91 | 0.050 |
Why?
|
Incidence | 3 | 2016 | 21552 | 0.050 |
Why?
|
Drug Approval | 1 | 2009 | 817 | 0.050 |
Why?
|
Telemedicine | 1 | 2019 | 3104 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2017 | 65409 | 0.050 |
Why?
|
Cohort Studies | 3 | 2014 | 41797 | 0.040 |
Why?
|
Guideline Adherence | 2 | 2013 | 2239 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3735 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39430 | 0.040 |
Why?
|
Inflammation | 2 | 2010 | 10865 | 0.040 |
Why?
|
Artifacts | 3 | 1994 | 1927 | 0.040 |
Why?
|
Terfenadine | 1 | 2019 | 15 | 0.040 |
Why?
|
Psychometrics | 1 | 2010 | 3072 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4906 | 0.040 |
Why?
|
Biopsy | 2 | 2010 | 6816 | 0.040 |
Why?
|
Disease Progression | 2 | 2014 | 13655 | 0.040 |
Why?
|
Cognition Disorders | 2 | 1990 | 3985 | 0.040 |
Why?
|
Premedication | 1 | 2019 | 246 | 0.040 |
Why?
|
Hospitalization | 2 | 2021 | 10845 | 0.040 |
Why?
|
Receptors, Cholinergic | 1 | 2019 | 244 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3246 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 1992 | 2969 | 0.040 |
Why?
|
Animals | 9 | 2010 | 169418 | 0.040 |
Why?
|
Prevalence | 2 | 2007 | 15880 | 0.040 |
Why?
|
Patient Participation | 1 | 2007 | 1450 | 0.040 |
Why?
|
Gene Rearrangement | 2 | 1994 | 1139 | 0.040 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4572 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4362 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2007 | 2433 | 0.040 |
Why?
|
Emergency Service, Hospital | 2 | 2015 | 7956 | 0.040 |
Why?
|
Decision Making | 1 | 2011 | 3961 | 0.030 |
Why?
|
Hepacivirus | 2 | 1994 | 1342 | 0.030 |
Why?
|
Health Surveys | 1 | 2007 | 4056 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 876 | 0.030 |
Why?
|
Amoxicillin | 1 | 2017 | 181 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 371 | 0.030 |
Why?
|
Molecular Sequence Data | 6 | 1996 | 17647 | 0.030 |
Why?
|
Air Pollutants | 1 | 2010 | 2905 | 0.030 |
Why?
|
Cefazolin | 1 | 2016 | 95 | 0.030 |
Why?
|
Paraffin Embedding | 2 | 1994 | 306 | 0.030 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2016 | 85 | 0.030 |
Why?
|
Acetaminophen | 1 | 2019 | 556 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2007 | 2585 | 0.030 |
Why?
|
HIV-1 | 1 | 1992 | 6966 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 1996 | 272 | 0.030 |
Why?
|
Nephritis, Interstitial | 1 | 2016 | 158 | 0.030 |
Why?
|
Emotions | 1 | 2007 | 2773 | 0.030 |
Why?
|
Base Sequence | 4 | 1994 | 12428 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1869 | 0.030 |
Why?
|
Perioperative Period | 1 | 2016 | 252 | 0.030 |
Why?
|
Internet | 1 | 2007 | 3123 | 0.030 |
Why?
|
Adrenergic Agonists | 1 | 2013 | 57 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 840 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10358 | 0.030 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2016 | 246 | 0.030 |
Why?
|
Prospective Studies | 2 | 2016 | 54914 | 0.030 |
Why?
|
Immunoglobulin Idiotypes | 1 | 1993 | 201 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8051 | 0.030 |
Why?
|
Evaluation Studies as Topic | 2 | 1992 | 1629 | 0.030 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4781 | 0.030 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 1992 | 32 | 0.030 |
Why?
|
Cardiolipins | 1 | 1992 | 83 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10647 | 0.030 |
Why?
|
Risk Factors | 3 | 2014 | 74915 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2019 | 1628 | 0.020 |
Why?
|
Hybridomas | 1 | 1993 | 444 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1992 | 417 | 0.020 |
Why?
|
Cytomegalovirus | 2 | 1993 | 755 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2019 | 1836 | 0.020 |
Why?
|
False Positive Reactions | 1 | 1994 | 962 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 1 | 1992 | 420 | 0.020 |
Why?
|
B-Lymphocyte Subsets | 1 | 1992 | 240 | 0.020 |
Why?
|
Partial Thromboplastin Time | 1 | 1991 | 204 | 0.020 |
Why?
|
Factor Xa | 1 | 1991 | 166 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15638 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2019 | 10273 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2408 | 0.020 |
Why?
|
Blood Coagulation Tests | 1 | 1991 | 271 | 0.020 |
Why?
|
Prognosis | 1 | 2011 | 30028 | 0.020 |
Why?
|
Epinephrine | 1 | 2013 | 795 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1413 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1816 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18478 | 0.020 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1992 | 648 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2723 | 0.020 |
Why?
|
Immunoglobulin A | 1 | 1993 | 990 | 0.020 |
Why?
|
Hepatitis B virus | 1 | 1993 | 530 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 26351 | 0.020 |
Why?
|
Glycoproteins | 1 | 1996 | 2206 | 0.020 |
Why?
|
Child | 4 | 2013 | 80863 | 0.020 |
Why?
|
Liver | 2 | 1994 | 7575 | 0.020 |
Why?
|
Clone Cells | 1 | 1992 | 1672 | 0.020 |
Why?
|
Acute Disease | 2 | 2010 | 7246 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 18048 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 1993 | 1529 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3438 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 1993 | 1481 | 0.020 |
Why?
|
Lyme Disease | 1 | 1993 | 631 | 0.020 |
Why?
|
Colonic Diseases, Functional | 1 | 1986 | 39 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2022 | 22293 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12561 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 1987 | 681 | 0.020 |
Why?
|
Signal Transduction | 1 | 2009 | 23638 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1994 | 4622 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 1986 | 262 | 0.020 |
Why?
|
Quality of Life | 1 | 2007 | 13497 | 0.020 |
Why?
|
Intestinal Absorption | 1 | 1986 | 400 | 0.020 |
Why?
|
Risk Assessment | 2 | 2017 | 24311 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1987 | 856 | 0.010 |
Why?
|
Plasma | 1 | 1987 | 588 | 0.010 |
Why?
|
Lymphoproliferative Disorders | 1 | 1987 | 531 | 0.010 |
Why?
|
Hepatitis C | 1 | 1994 | 1594 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 1994 | 11138 | 0.010 |
Why?
|
Logistic Models | 2 | 2013 | 13324 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8908 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10784 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11249 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9687 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1987 | 1308 | 0.010 |
Why?
|
Patient Discharge | 1 | 2013 | 3471 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12096 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6521 | 0.010 |
Why?
|
Angiotensin I | 1 | 1979 | 53 | 0.010 |
Why?
|
Angiotensins | 1 | 1979 | 141 | 0.010 |
Why?
|
Colon | 1 | 1986 | 1804 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1988 | 1668 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9425 | 0.010 |
Why?
|
Methacholine Chloride | 1 | 1997 | 220 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1992 | 12813 | 0.010 |
Why?
|
Renin | 1 | 1979 | 642 | 0.010 |
Why?
|
Hyperkalemia | 1 | 1979 | 233 | 0.010 |
Why?
|
Angiotensin II | 1 | 1979 | 849 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1994 | 20231 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1994 | 224 | 0.010 |
Why?
|
RNA Probes | 1 | 1994 | 111 | 0.010 |
Why?
|
Histological Techniques | 1 | 1994 | 194 | 0.010 |
Why?
|
Pilot Projects | 1 | 2007 | 8730 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26395 | 0.010 |
Why?
|
Borrelia burgdorferi Group | 1 | 1993 | 97 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1996 | 13452 | 0.010 |
Why?
|
Neurotensin | 1 | 1992 | 60 | 0.010 |
Why?
|
Diabetes Complications | 1 | 1979 | 1322 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36497 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42623 | 0.010 |
Why?
|
Pregnancy | 1 | 1992 | 30179 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1994 | 2477 | 0.010 |
Why?
|
Tubulin | 1 | 1992 | 695 | 0.000 |
Why?
|
Neoplasms | 1 | 2017 | 22386 | 0.000 |
Why?
|
Antibody Formation | 1 | 1993 | 1393 | 0.000 |
Why?
|
Sequence Alignment | 1 | 1992 | 2184 | 0.000 |
Why?
|
DNA Primers | 1 | 1992 | 2826 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1996 | 2326 | 0.000 |
Why?
|
Lactulose | 1 | 1986 | 32 | 0.000 |
Why?
|
Mice | 1 | 1993 | 82045 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 3816 | 0.000 |
Why?
|
Hydrogen | 1 | 1986 | 172 | 0.000 |
Why?
|
RNA, Viral | 1 | 1994 | 2865 | 0.000 |
Why?
|
Fetus | 1 | 1992 | 1883 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1996 | 12450 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 1997 | 14766 | 0.000 |
Why?
|
Intestine, Small | 1 | 1986 | 1218 | 0.000 |
Why?
|
Gene Expression | 1 | 1992 | 7605 | 0.000 |
Why?
|
Hypertension | 1 | 1979 | 8611 | 0.000 |
Why?
|
Cell Line | 1 | 1992 | 15609 | 0.000 |
Why?
|
Models, Biological | 1 | 1992 | 9505 | 0.000 |
Why?
|
Rats | 1 | 1992 | 23839 | 0.000 |
Why?
|
Glucose Tolerance Test | 1 | 1979 | 1181 | 0.000 |
Why?
|
Potassium | 1 | 1979 | 1319 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 1979 | 5887 | 0.000 |
Why?
|